[go: up one dir, main page]

IN2014MU03703A - - Google Patents

Download PDF

Info

Publication number
IN2014MU03703A
IN2014MU03703A IN3703MU2014A IN2014MU03703A IN 2014MU03703 A IN2014MU03703 A IN 2014MU03703A IN 3703MU2014 A IN3703MU2014 A IN 3703MU2014A IN 2014MU03703 A IN2014MU03703 A IN 2014MU03703A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN3703MU2014 priority Critical patent/IN2014MU03703A/en
Publication of IN2014MU03703A publication Critical patent/IN2014MU03703A/en
Priority to US14/946,947 priority patent/US9682045B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3703MU2014 2014-11-21 2014-11-21 IN2014MU03703A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3703MU2014 IN2014MU03703A (fr) 2014-11-21 2014-11-21
US14/946,947 US9682045B2 (en) 2014-11-21 2015-11-20 Stable pharmaceutical compositions of thyroid hormone drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3703MU2014 IN2014MU03703A (fr) 2014-11-21 2014-11-21

Publications (1)

Publication Number Publication Date
IN2014MU03703A true IN2014MU03703A (fr) 2015-07-22

Family

ID=56009121

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3703MU2014 IN2014MU03703A (fr) 2014-11-21 2014-11-21

Country Status (2)

Country Link
US (1) US9682045B2 (fr)
IN (1) IN2014MU03703A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025181833A1 (fr) * 2024-03-01 2025-09-04 Srushti Pharmaceuticals Pvt Ltd Composition à base de pastilles de sodium de lévothyroxine et procédé de préparation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10231931B1 (en) 2018-03-23 2019-03-19 Genus Lifesciences Inc. Thyroid hormone oral dosage forms and methods of using the same
EP3781126B1 (fr) * 2018-04-16 2022-05-04 Ioulia Tseti Préparations de médicaments d'hormone thyroïdienne de poudre sèche pour administration à inhaler
TW202227047A (zh) * 2020-10-09 2022-07-16 日商Ａｓｋａ製藥股份有限公司 甲狀腺荷爾蒙的製劑化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
DE19541128C2 (de) 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
KR20040100835A (ko) 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US8293272B2 (en) 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
WO2013033194A1 (fr) * 2011-08-30 2013-03-07 Fresenius Kabi Usa, Llc Formulations de lévothyroxine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025181833A1 (fr) * 2024-03-01 2025-09-04 Srushti Pharmaceuticals Pvt Ltd Composition à base de pastilles de sodium de lévothyroxine et procédé de préparation

Also Published As

Publication number Publication date
US20160143855A1 (en) 2016-05-26
US9682045B2 (en) 2017-06-20

Similar Documents

Publication Publication Date Title
BR112016018406A2 (fr)
BR112016013482A2 (fr)
BR112016018895A2 (fr)
BR112016016195A2 (fr)
BR112016016225A2 (fr)
BR112016016602A2 (fr)
BR112016017303A2 (fr)
BR112016018070A2 (fr)
BR112016017913A2 (fr)
BR112016018868A2 (fr)
BR112016017950A2 (fr)
BR112016016106A2 (fr)
BR112016017262A2 (fr)
BR112016017713A2 (fr)
BR112016018578A2 (fr)
BR112016016298A2 (fr)
BR112016015645A2 (fr)
BR112016016389A2 (fr)
BR112016015293A2 (fr)
BR112016017675A2 (fr)
BR112016018896A2 (fr)
BR112016017949A2 (fr)
BR112016018686A2 (fr)
BR112016018337A2 (fr)
BR112016019085A2 (fr)